Method for producing thiazolidinediones, and new thiazolidinediones
AssigneeRoche Diagnostics GmbH
InventorsHans-Frieder Kühnle, Ernst-Christian Witte, Hans-Peter Wolff
Life of this patent
Estimating the term…
Abstract
Improved process of compounds of formula III in which A denotes CH═CH or S W denotes O X denotes S, O or NR2 in which the residue R2 is hydrogen or C1-C6 alkyl, Y denotes CH or N R denotes naphthyl, thienyl or phenyl which is optionally monosubstituted or disubstituted with C1-C3 alkyl, CF3, C1-C3 alkoxy, F, Cl or bromine, R1 denotes hydrogen or C1-C6 alkyl and n denotes 1-3 by reducing a compound of the general formula IV, in which A, W, X, Y, R, R1 and n have the meanings stated above with activated aluminum in a protic solvent, as well as new compounds of formula III and pharmaceutical preparations containing these compounds.
Claims1
The compound 5-{4-[2-(5-methyl-2-thien-2-yl)-oxazol-4-yl)-ethoxy]-benzo[b]thiophen-7-ylmethyl}-thiazolidine-2,4-dione, or a tautomer, enantiomer, or diastereomer thereof or a physiologically tolerated salt of said compound, tautomer, enantiomer or diastereomer.
Dependencies are inferred from the claim text.